Fibroblast contraction assay

Reagents:

The process of fibrosis in cardiomyopathy depends on the transition of fibroblast to myofibroblast. Fibroblast contractivity is the ultimate approach to assess myofibroblast formation. We use TGF-beta to induce myofibroblast formation using the following protocol and identify molecules which may control the transition.

1. Seed NIH 3T3 fibroblast in 6-well plate, 600, 000 cells per well.

2. Next day, treat cells with recombinant TGF-beta for 24 hrs.

3. Next day, transfect plamids of your favourite molecules to assess effects on myofibroblast contraction.

4. Next day, harvest cells for collagen gel culture in 24 well plates.

5. For each well, we use 100 ul cell suspension of around 2-5 million cells and 500 ul collagen gel mix.

6. Prepare collagen gel mix by the following regime for each well (all provided in the Assay kit). Keep all the solutions on ice. In a cold sterile tube, add collagen solution, 5 X DMEM, mix well. Then add neutralization solution, mix it immediately and keep the gel mix on ice.

7. In labelled cold sterile tubes, add 100 μl of cells and 500 μl of collagen gel mix. Mix well while still keeping them on ice.

8. Add the cell-collagen mix into the 24 well plate. Avoid bubbles. Swirl gently to cover the complete surface of well.

9. Incubate in 37 C for 1 hrs.

10. Detach the gel from the plate with a sterile blade or needle.

The Gel should be free floating else it won’t contract.

11. Add 1 ml culture media (DMEM - 10% FCS) at the top of the gel very gently.

12. Take picture for 0 hour. Then as often as required.

Courtesy: Bajaj N.

Comments

Add a comment
Site News
New feature:
You can add comments on protocols now. Just go to any individual method page and click on the "Add a comment" link.

Highlight of the month
SIRT6 links glucose and lipid metabolism

SIRT1, a histone deacetylase, has drawn considerable attention due to its important roles in metabolic regulation and longevity. SIRT1 is induced by fasting and suppressed by feeding. SIRT1 increases glucose production and beta oxidation in liver to meet energy needs during food deprivation. Another member of SIRT family, SIRT6 follows similar expression patterns as SIRT1. The function of SIRT6 in metabolic regulation remains unknown.

Kim and colleagues found SIRT1 can regulate SIRT6 expression in liver. Specifically, SIRT1 functions together with FOXO3a and stimulates SIRT6 transcription during fasting. The activation of SIRT6 directly suppresses gene expression of metabolic enzymes involved in triglyceride synthesis and glycolysis in liver. Deficiency of SIRT6 causes increases of glucose utilization, reduced beta oxidation and as a result, fatty liver. More importantly, Kim et al found the expression of SIRT6 is decreased in human fatty liver samples which indicates SIRT6 may play critical roles in liver steatosis in clinical settings. This study landed in Cell Metabolism of this month. ... Read more highlights.